H.R. 225: National Pediatric Research Network Act of 2013

Introduced:
Jan 14, 2013 (113th Congress, 2013–2015)
Sponsor:
Rep. Lois Capps [D-CA24]
Status:
Passed House

The bill’s title was written by the bill’s sponsor. H.R. stands for House of Representatives bill.

Track this bill

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


2/4/2013--Passed House without amendment.
National Pediatric Research Network Act of 2013 - Amends the Public Health Service Act to authorize the Director of the National Institutes of Health (NIH), in carrying out the Pediatric Research Initiative, to act through the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development to provide for the establishment of a National Pediatric Research Network. Authorizes the Director of the Institute to award funding to public or private nonprofit entities for:
(1) planning, establishing, or strengthening pediatric research consortia; and
(2) providing basic operating support for such consortia, including to meet unmet needs for pediatric research through basic, clinical and behavioral translational research and the training of researchers in pediatric research techniques.
Authorizes the Director of NIH to make awards for not more than 20 pediatric research consortia, which must be formed from a collaboration of cooperating institutions, be coordinated by a lead institution, agree to disseminate scientific findings, and meet requirements prescribed by the Director of NIH. Allows such support to be for a period of five years, with additional extensions at the discretion of the Director of NIH. Requires the Director of NIH to provide for the coordination of activities among the consortia and to require the periodic preparation and submission of reports on their activities.
Requires each pediatric research consortium receiving an award to assist the Centers for Disease Control and Prevention (CDC) in the establishment or expansion of patient registries and other surveillance systems as appropriate and upon request by the CDC. Requires the Director of NIH to ensure that an appropriate number of such awards are awarded to consortia that agree to:
(1) focus primarily on pediatric rare diseases or conditions; and
(2) conduct or coordinate multi-site clinical trials of therapies for, or approaches to, the prevention, diagnosis, or treatment of pediatric rare diseases or conditions.
Requires the Director of NIH to establish a data coordinating center to:
(1) distribute such findings;
(2) provide assistance in the design and conduct of collaborative research projects and the management, analysis, and storage of data associated with such projects; and
(3) organize and conduct multi-site monitoring activities.
Requires the Director of NIH to:
(1) require the data coordinating center to provide regular reports to the Director of NIH and the Commissioner of Food and Drugs (FDA) on research conducted by consortia, including information on enrollment in clinical trials and the allocation of resources with respect to such research; and
(2) incorporate such information into NIH's biennial reports.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


This summary can be found at http://www.gop.gov/bill/113/1/hr225.

Background

On September 19, 2012, the House passed H.R. 6163 by voice vote.  H.R. 6168 is nearly identical to H.R. 225, with changes being limited to minor technical corrections and updates.  For more information, see H.R 6163 here.

Summary

H.R. 225 authorizes the Director of the National Institutes of Health (NIH), through the Director of the National Institute of Child Health and Human Development, to establish up to 20 National Pediatric Research Consortia.  Each consortia would be composed of multiple institutions that are involved with pediatric research.  Each consortia will function in a “a spoke and hub fashion”.  These consortia will be selected through a competitive, peer-review process and would be open to private or public nonprofit agencies.

Cost

CBO is in the process of scoring the bill. 

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

The bill contains the following citations to other parts of U.S. law:

United States Code

The United States Code is the compilation of permanent laws enacted by Congress. Temporary and other non-permanent laws do not appear in the United States Code. (About half of the United States Code is the law itself, called positive law. The other half is merely a compilation of the laws but has no legal significance.)

  • Title 42: THE PUBLIC HEALTH AND WELFARE
  • Chapter 6A: PUBLIC HEALTH SERVICE
  • Subchapter III: NATIONAL RESEARCH INSTITUTES
  • Part B: General Provisions Respecting National Research Institutes
  • Section 284h: Pediatric Research Initiative